161 related articles for article (PubMed ID: 31397256)
1. Drug repurposing for the treatment of alveolar echinococcosis:
Fabbri J; Pensel PE; Albani CM; Arce VB; Mártire DO; Elissondo MC
Parasitology; 2019 Nov; 146(13):1620-1630. PubMed ID: 31397256
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
3. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
5. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives.
Spicher M; Roethlisberger C; Lany C; Stadelmann B; Keiser J; Ortega-Mora LM; Gottstein B; Hemphill A
Antimicrob Agents Chemother; 2008 Sep; 52(9):3447-50. PubMed ID: 18625777
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
10. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug.
Fabbri J; Pensel PE; Albani CM; Lopez LM; Simonazzi A; Bermudez JM; Palma SD; Elissondo MC
Parasitology; 2020 Aug; 147(9):1026-1031. PubMed ID: 32338226
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo.
Yuan M; Luo Y; Xin Q; Gao H; Zhang G; Jing T
Vet Parasitol; 2016 Aug; 226():38-43. PubMed ID: 27514881
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
13. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
Stettler M; Rossignol JF; Fink R; Walker M; Gottstein B; Merli M; Theurillat R; Thormann W; Dricot E; Segers R; Hemphill A
Int J Parasitol; 2004 Apr; 34(5):615-24. PubMed ID: 15064126
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
15. Anti-echinococcal activity of menthol and a novel prodrug, menthol-pentanol, against Echinococcus multilocularis.
Fabbri J; Clemente CM; Elissondo N; Gambino G; Ravetti S; Hergert LY; Palma SD; Elissondo MC
Acta Trop; 2020 May; 205():105411. PubMed ID: 32101761
[TBL] [Abstract][Full Text] [Related]
16. In vitro efficacy of ampelopsin against Echinococcus granulosus and Echinococcus multilocularis.
Xin Q; Yuan M; Li H; Lu J; Song X; Jing T
J Vet Med Sci; 2019 Dec; 81(12):1853-1858. PubMed ID: 31748438
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
18. 2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.
Xin Q; Lv W; Xu Y; Luo Y; Zhao C; Wang B; Yuan M; Li H; Song X; Jing T
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010618. PubMed ID: 35849619
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
20. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
